Kyoto University hospitals starts clinical trials of cellular therapy against Parkinson’s disease

In the doctor-initiated trial, dopamine neural progenitor cells derived from allogenic iPS cells are administered to patients suffering from Parkinson’s disease. The experimental design has been developed byo Jun TAKAHASHI at CiRA of Kyoto University in collaboration with Dainippon Sumitomo Pharma.

Dainippon Sumitomo Pharma news release, July 31, 2018

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny